OLPX · Olaplex Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99.37M | - | $114.58M | $106.28M | $96.98M | - | $119.08M | $103.94M | $98.91M | - |
| Cost of Revenue | $27.71M | - | $35.38M | $30.65M | $29.62M | - | $37.35M | $31.51M | $27.56M | - |
| Gross Profit | $71.66M | - | $79.20M | $75.64M | $67.36M | - | $81.73M | $72.44M | $71.34M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $65.95M | - | $64.11M | $65.91M | $47.99M | - | $42.96M | $45.42M | $40.44M | - |
| Total Operating Expenses | $76.77M | - | $75.02M | $76.84M | $58.88M | - | $53.74M | $56.16M | $51.73M | - |
| D&A | $82.0K | - | - | - | $87.0K | - | - | - | $149.0K | - |
| Operating Income | ($5.11M) | - | $4.18M | ($1.20M) | $8.48M | - | $28.00M | $16.28M | $19.62M | - |
| Interest Expense | $7.10M | - | $7.70M | $12.40M | $13.70M | - | $15.60M | $8.30M | $14.50M | - |
| Income Tax | ($4.40M) | - | ($2.43M) | ($1.32M) | $416.0K | - | $4.86M | $1.90M | $2.62M | - |
| Net Income | ($5.29M) | - | $11.13M | ($7.74M) | $465.0K | - | $14.80M | $5.78M | $7.75M | - |
| EPS - Basic | ($0.01) | - | $0.02 | ($0.01) | $0.00 | - | $0.02 | $0.01 | $0.01 | - |
| EPS - Diluted | ($0.01) | - | $0.02 | ($0.01) | $0.00 | - | $0.02 | $0.01 | $0.01 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $326.17M | $318.73M | $286.38M | $289.34M | $580.89M | $585.97M | $538.83M | $507.93M | $507.51M | $466.40M |
| Accounts Receivable | $37.50M | $29.01M | $49.73M | $32.64M | $23.83M | $14.93M | $34.89M | $33.98M | $25.81M | $40.92M |
| Inventory | $66.36M | $60.22M | $73.26M | $78.32M | $79.18M | $75.17M | $85.91M | $100.16M | $94.64M | $95.92M |
| Accounts Payable | $29.18M | $8.12M | $23.50M | $25.06M | $24.33M | $10.42M | $11.36M | $23.02M | $17.22M | $7.07M |
| Current Assets | $446.26M | $470.35M | $473.22M | $462.67M | $703.86M | $689.71M | $669.71M | $654.45M | $639.50M | $613.20M |
| Total Assets | $1.46B | $1.50B | $1.51B | $1.52B | $1.77B | $1.77B | $1.76B | $1.76B | $1.75B | $1.74B |
| Current Liabilities | $71.15M | $102.63M | $113.68M | $119.94M | $65.56M | $64.65M | $56.56M | $70.62M | $59.73M | $56.14M |
| Long-term Debt | $352.48M | $352.29M | $352.10M | $351.90M | $642.38M | $643.71M | $645.04M | $646.37M | $647.70M | $649.02M |
| Total Liabilities | $582.21M | $618.10M | $625.47M | $642.75M | $892.60M | $893.32M | $879.43M | $893.44M | $897.66M | $895.37M |
| Stockholders' Equity | $877.99M | $879.39M | $888.75M | $874.17M | $878.33M | $874.40M | $879.73M | $863.32M | $855.71M | $844.97M |
| Retained Earnings | $531.43M | $536.71M | $549.82M | $538.69M | $546.43M | $545.97M | $554.76M | $539.97M | $534.19M | $526.44M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.50M | - | - | - | ($2.92M) | - | - | - | $43.71M | - |
| Investing Cash Flow | ($288.0K) | - | - | - | ($996.0K) | - | - | - | ($1.08M) | - |
| Financing Cash Flow | $227.0K | - | - | - | ($1.16M) | - | - | - | ($1.52M) | - |
| CapEx | $146.0K | - | - | - | $48.0K | - | - | - | $451.0K | - |
| Free Cash Flow | $7.35M | - | - | - | ($2.96M) | - | - | - | $43.26M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 72.1% | - | 69.1% | 71.2% | 69.5% | - | 68.6% | 69.7% | 72.1% | - |
| Operating margin | -5.1% | - | 3.7% | -1.1% | 8.7% | - | 23.5% | 15.7% | 19.8% | - |
| EBITDA margin | -5.1% | - | - | - | 8.8% | - | - | - | 20.0% | - |
| Net margin | -5.3% | - | 9.7% | -7.3% | 0.5% | - | 12.4% | 5.6% | 7.8% | - |
| Free cash flow margin | 7.4% | - | - | - | -3.1% | - | - | - | 43.7% | - |
| FCF / Net income | -1.39 | - | - | - | -6.38 | - | - | - | 5.58 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 66.4% | - | 56.0% | 62.0% | 49.5% | - | 36.1% | 43.7% | 40.9% | - |
| Effective tax rate | - | - | -27.9% | - | 47.2% | - | 24.7% | 24.7% | 25.3% | - |
| Return on assets | -0.4% | - | 0.7% | -0.5% | 0.0% | - | 0.8% | 0.3% | 0.4% | - |
| Return on equity | -0.6% | - | 1.3% | -0.9% | 0.1% | - | 1.7% | 0.7% | 0.9% | - |
| Return on invested capital | -0.3% | - | 0.3% | -0.1% | 0.3% | - | 1.4% | 0.8% | 1.0% | - |
| Liquidity | ||||||||||
| Current ratio | 6.27 | 4.58 | 4.16 | 3.86 | 10.74 | 10.67 | 11.84 | 9.27 | 10.71 | 10.92 |
| Quick ratio | 5.34 | 4.00 | 3.52 | 3.20 | 9.53 | 9.51 | 10.32 | 7.85 | 9.12 | 9.21 |
| Cash ratio | 4.58 | 3.11 | 2.52 | 2.41 | 8.86 | 9.06 | 9.53 | 7.19 | 8.50 | 8.31 |
| Leverage | ||||||||||
| Debt / Equity | 0.40 | 0.40 | 0.40 | 0.40 | 0.73 | 0.74 | 0.73 | 0.75 | 0.76 | 0.77 |
| Debt / Assets | 0.24 | 0.24 | 0.23 | 0.23 | 0.36 | 0.36 | 0.37 | 0.37 | 0.37 | 0.37 |
| Debt / EBITDA | - | - | - | - | 75.02 | - | - | - | 32.77 | - |
| Interest coverage | -0.7x | - | 0.5x | -0.1x | 0.6x | - | 1.8x | 2.0x | 1.4x | - |
| Equity multiplier | 1.66 | 1.70 | 1.70 | 1.74 | 2.02 | 2.02 | 2.00 | 2.03 | 2.05 | 2.06 |
| Liabilities / Assets | 0.40 | 0.41 | 0.41 | 0.42 | 0.50 | 0.51 | 0.50 | 0.51 | 0.51 | 0.51 |
| Efficiency | ||||||||||
| Asset turnover | 0.07 | - | 0.08 | 0.07 | 0.05 | - | 0.07 | 0.06 | 0.06 | - |
| Inventory turnover | 0.42 | - | 0.48 | 0.39 | 0.37 | - | 0.43 | 0.31 | 0.29 | - |
| Days sales outstanding | 138d | - | 158d | 112d | 90d | - | 107d | 119d | 95d | - |
| Days inventory outstanding | 874d | - | 756d | 933d | 976d | - | 840d | 1160d | 1253d | - |
| Days payable outstanding | 384d | - | 242d | 298d | 300d | - | 111d | 267d | 228d | - |
| Cash conversion cycle | 628d | - | 672d | 746d | 766d | - | 836d | 1013d | 1120d | - |
| Valuation | ||||||||||
| P / E | - | - | 65.5x | - | - | - | 117.5x | 154.0x | 192.0x | - |
| P / B | 1.5x | - | 1.0x | 1.1x | 1.0x | - | 1.8x | 1.2x | 1.5x | - |
| P / S | 13.7x | - | 7.6x | 8.8x | 8.7x | - | 13.1x | 9.8x | 12.9x | - |
| EV / EBITDA | - | - | - | - | 106.0x | - | - | - | 71.5x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 2.5% | - | -3.8% | 2.3% | -1.9% | - | -3.6% | -4.8% | -13.1% | - |
| Revenue CAGR (3y) | -4.4% | - | -13.4% | -20.4% | -19.5% | - | 10.0% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 6.4% | - | -3.1% | 4.4% | -5.6% | - | -2.2% | -6.5% | -11.7% | - |
| Operating income growth (YoY) | - | - | -85.1% | - | -56.8% | - | -23.8% | -13.2% | -44.8% | - |
| Net income growth (YoY) | - | - | -24.8% | - | -94.0% | - | -27.3% | -6.1% | -63.1% | - |
| EPS growth (YoY) | - | - | 0.0% | - | - | - | -33.3% | 0.0% | -66.7% | - |
| EPS CAGR (3y) | - | - | -39.4% | - | - | - | -37.0% | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | -9.8% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.0% | 0.6% | 1.0% | 1.3% | 2.6% | 3.5% | 4.7% | 5.6% | 6.1% | 8.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$422.96M totalReportable Segment$422.96M · 100.0%
Geographic
$422.96M totalNon Us$218.98M · 51.8%
US$203.98M · 48.2%
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing OLAPLEX HOLDINGS against the 5 most active filers in the same SIC group.